Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Screening Period	STARTED	DBV712 250 μg	0
Screening Period	STARTED	Placebo	0
Screening Period	STARTED	Screened	500
Screening Period	COMPLETED	DBV712 250 μg	0
Screening Period	COMPLETED	Placebo	0
Screening Period	COMPLETED	Screened	356
Screening Period	NOT COMPLETED	DBV712 250 μg	0
Screening Period	NOT COMPLETED	Placebo	0
Screening Period	NOT COMPLETED	Screened	144
Treatment and Follow-up Periods	STARTED	DBV712 250 μg	238
Treatment and Follow-up Periods	STARTED	Placebo	118
Treatment and Follow-up Periods	STARTED	Screened	0
Treatment and Follow-up Periods	COMPLETED	DBV712 250 μg	213
Treatment and Follow-up Periods	COMPLETED	Placebo	107
Treatment and Follow-up Periods	COMPLETED	Screened	0
Treatment and Follow-up Periods	NOT COMPLETED	DBV712 250 μg	25
Treatment and Follow-up Periods	NOT COMPLETED	Placebo	11
Treatment and Follow-up Periods	NOT COMPLETED	Screened	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02636699/flow